SGEN Financial Facts
Investment income, net: 660KIncome (loss) from operations: -32.41M
See Full Income Statement
Deferred rent and other long-term liabilities: 2.81M
Total assets: 849.91M
See Full Balance Sheet
Seattle Genetics Inc. (SGEN) Earnings
|
Expand Research on SGEN
Next EPS Date | N/A | EPS Growth Rate | +100.0% *Last Qtr. |
---|---|---|---|
Average EPS % Beat Rate | -17.8% | Revenue Growth Rate | -100.0% *Last Qtr. |
Average % Move 1-Wk after EPS | +3.3% | Normal Earnings Time | After Close |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
10/30/14 | Q314 | -$0.13 | -$0.24 | +$0.11 | $75.8M | $66.9M | N/A | Details | |||
2/8/24 | Q423 | N/A | -$0.95 | N/A | N/A | $682.86M | N/A | N/A | |||
11/1/23 | Q323 | -$1.15 | -$0.82 | -$0.33 | $571M | $635.08M | Details | ||||
4/27/23 | Q123 | -$0.93 | -$0.83 | -$0.10 | $519.72M | $514.99M | Details | ||||
10/29/20 | Q320 | $3.50 | $0.50 | +$3.00 | $1.06B | $508.49M | = | Details | |||
8/2/23 | Q223 | -$1.13 | -$0.80 | -$0.33 | $603.83M | $560.64M | Details | ||||
10/28/21 | Q321 | -$1.61 | -$0.57 | -$1.04 | $424.1M | $383.31M | N/A | Details | |||
7/28/22 | Q222 | -$0.47 | -$0.85 | +$0.38 | $498M | $438.23M | Details |